USD0.000æéå€ååŒÂ  (ET)
3.81MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
VVOS ãã©ã³ã¹ã·ãŒã
Vivos Therapeutics Incã®è²¡åå¥å
šæ§ãè©äŸ¡ãããã¡ã³ãã¡ã³ã¿ã«ãºãåæããæµåæ§ãã¬ãã¬ããžãæ ªäž»è³æ¬å©ççãªã©ã®äž»èŠæ¯çãèšç®ããããã«ããã¡ãã§Vivos Therapeutics Incã®å¹Žæ¬¡ãŸãã¯ååæã®ãã©ã³ã¹ã·ãŒããã確èªããã ããŸãã
ãããã質å
VVOS æ ªãåæããéã«æãéèŠãªè²žå察ç
§è¡šã®ææšã¯äœã§ããïŒ
îéèŠãªææšã«ã¯ãçŸéããã³çææè³ãç·è³ç£ãæµåè³ç£ãç·è² åµãæµåè² åµãé·æåµåãæ ªäž»è³æ¬ãå©çå°äœéãåšåº«ã売äžåµæš©ãéè»¢è³æ¬ãæµåæ¯çãåœåº§æ¯çãè² åµè³æ¬æ¯çãèªå·±è³æ¬å©ççãå«ãŸããŸããæè³å®¶ã¯éåžžãããããç·åçã«èŠãŠã1ã€ã®æ°å€ã«é Œããªãããã«åæããŸãã
è³ç£ãè² åµãããã³æ ªäž»è³æ¬ã®éãã¯äœã§ããïŒ
îè³ç£ã¯ãçŸéã売äžåµæš©ãåšåº«ãæè³ãåºå®è³ç£ãªã©ãäŒæ¥ãææãŸãã¯ç®¡çããŠãããªãœãŒã¹ã§ããè² åµã¯ãäŒæ¥ãè² ã£ãŠãã矩åã§ãããè²·æéãåµåããªãŒã¹ããã³çšéãå«ãŸããŸããæ ªäž»è³æ¬ã¯ãè³ç£ããè² åµãå·®ãåŒããçŽè³ç£äŸ¡å€ã§ãã
æµåé
ç®ãšéæµåé
ç®ã®éãã¯äœã§ããïŒ
îæµåè³ç£ãšæµåè² åµã¯ãäžè¬çã«1幎ãŸãã¯1å¶æ¥ãµã€ã¯ã«ã®ãã¡ã«çŸéåã䜿çšãæ¯æãããŸãã¯æž
ç®ãããããšãæåŸ
ãããŸããéæµåè³ç£ããã³éæµåè² åµã¯ãåºå®è³ç£ãé·ææè³ãç¹°å»¶çšéè³ç£ããã³é·æåµåããªãŒã¹åµåãªã©ã®é·æé
ç®ã§ãã
Vivos Therapeutics Inc ã¯ã©ããããã®çŸéãæã£ãŠããŸããïŒ
îæè¿ã®ååæã®å ±åã§ã¯ãVivos Therapeutics Inc ã®çŸéåã³çŸéåçç©ã¯ 2.11M ã§ããã
Vivos Therapeutics Inc ã®ç·è² åµã¯ãããã§ããïŒ
îVivos Therapeutics Inc ã¯ææ°ã®å ±åååæã«ãããŠãç·è² åµã 26.70M ã§ãæµåè² åµã 18.08M ã§ãéæµåè² åµã 8.63M ã§ããããšãå ±åããŸããã
Vivos Therapeutics Inc ã®ç·è³ç£ã¯ãããã§ããïŒ
îæè¿ã®å ±åååæã«ãããŠãVivos Therapeutics Inc ã®ç·è³ç£ã¯ 25.15M ã§ãæµåè³ç£ã 4.38M ãéæµåè³ç£ã 20.77M ã§ããããšãå ±åããŸããã
Vivos Therapeutics Inc ã®æ ªäž»è³æ¬ã¯ã©ã®ãããã§ããïŒ
îVivos Therapeutics Inc ã¯ææ°ã®å ±åååæã«ãããŠãç·æ ªäž»è³æ¬ã -1.55M ã§ãããšå ±åããŸããã